View as Webpage

Weekly Newsletter | November 18th, 2026

Innovate, Discover, Transform - Science Jobs Await

Analytical Development Scientist III
Avid Bioservices - Tustin, CA
Full-time
Posted: Nov 11, 2026
Salary: $109,000.00 - $145,000.00 Annually
Application Deadline: N/A
Accounting Operations Manager
Critical Innovations - Lawndale, CA
Full-time
Posted: Nov 5, 2026
Salary: $110,000.00 - $125,000.00 Annually
Application Deadline: N/A
Sr. Systems Engineer
huMannity Medtec - Alfred Mann Foundation - Santa Clarita, CA
Full-time
Posted: Nov 4, 2026
Salary: $121,000.00 - $135,000.00 Annually
Application Deadline: Dec 31, 2026
Quality Control Analyst
AIVITA Biomedical - Irvine, CA
Full-time
Posted: Oct 23, 2026
Application Deadline: N/A
Research Bioinformatician II - Knott Lab
Cedars-Sinai - Los Angeles, CA
Full-time
Posted: Oct 23, 2026
Application Deadline: N/A

Hiring? Post your job for free

The SoCalBio Job Board is free for members. Email scbc@socalbio.org to set up an account, post jobs, and have them featured in the next newsletter.

New Program Announcment

Now Accepting Applications: Founders’ Bench Award for Ophthalmology Innovation  

SoCalBio partner University Lab Partners (ULP) has launched the Founders’ Bench Award, in partnership with Bausch + Lomb and with UC Irvine’s Gavin Herbert Eye Institute as academic partner. The new program supports early-stage companies developing eye health solutions with six months of funded wet-lab bench space at ULP in UCI Research Park.

Awardees also receive:



  • Access to shared scientific equipment
  • Mentoring from Bausch + Lomb scientists and business leaders, plus experts in regulatory, IP, clinical development and finance
  • Fundraising-readiness support, including NIH SBIR/STTR grant consulting
  • Connections to UCI faculty, core facilities and talent
  • A Month 6 investor showcase


Who should apply: Pre-seed and seed founders, and academic or corporate spinouts with a Southern California link and a real need for bench space. ULP is looking for ideas in eye drug delivery, treatments, cell and gene therapies, diagnostics and imaging, and surgical or digital tools.

Important dates:

  • Apply by: Monday, November 30
  • Pitch & Award Night: Tuesday, February 2, 2027

News Updates


J&J to buy eye disease biotech Ollin Biosciences for up to $3.3 billion | CNBC

Johnson & ⁠Johnson said on Monday it had agreed to buy Texas-based biotech Ollin Biosciences for up to $3.33 billion, ⁠expanding its pipeline of eye disease therapies.


Science Corporation raises $400M to commercialize BCI device | MedTechDive

The device, which Science has launched in Europe, is designed to restore the sight of people with some forms of vision loss.


Lilly to buy Calytrix for up to $1.5 billion in rare blood cancer bet | Reuters

Eli Lilly has agreed to acquire privately held biotech Calytrix Bio for up to $1.5 billion in cash, ​as it looks to expand the development of treatments for ‌rare blood cancers.


AI drugmaker Isomorphic restocks with $5B fundraise | BioPharmaDive

Even as the larger AI industry faces turmoil, investors have given Isomorphic the two largest cash infusions in the biotech sector this year.


White House pulls nomination of Heidi Overton to lead FDA | TheHill

The White House withdrew the nomination of Heidi Overton to lead the Food and Drug Administration (FDA) amid opposition from Senate Republicans, it confirmed to The Hill.


Chinese biotech competition and the payer squeeze are reshaping European biotech | Labiotech

At BIO-Europe last week one preclinical company explained how it was building its drug development program with a focus on fitting prescribing and reimbursement models.


Isomorphic Labs breaks biotech VC fundraising record with $5B series C | BioSpace

After securing $2.1 billion this May, AI-driven drug designer Isomorphic Labs is back with more money—a lot more—securing the industry’s largest private fundraise ever.


Pfizer enters in vivo CAR-T space via 3-program, $2.6B deal with China’s Starna | FierceBiotech

Pfizer has decided to join the in vivo CAR-T race, penning a $2.6 billion deal for three preclinical candidates from China’s Starna Therapeutics.

Advancing Future Leaders in Biotechnology


SoCalBio BioGENEius connects Southern California high school students with real-world opportunities in biotechnology, medical devices and life sciences through mentorship, hands-on experiences, industry exposure, and career development.


Three ways to support the students


Donate. Your gift funds awards, plaques and certificates for winners and runners-up. 100% of your support goes to the students.

Judge. Join the committee that selects the brightest students from California State Science and Engineering Fair entries in our region. Contact Tom Lobl.

Mentor. Build a relationship with an awardee as they prepare for college and a career in technology.

Applications Now Open for the 2027 SoCalBio Annual Investor Conference!


Showcase your company to a network of angel investors, venture capitalists, and industry leaders at the 2027 SoCalBio Annual Investor Conference. Last year, we had over 20 investors and over 200 one-on-one meetings scheduled.


Applicants will undergo a screening process with our Innovation Catalysts Committee. Selected companies will receive complimentary admission to the conference to present, as well as early registration for 1:1 networking meetings with investors.

Thank you to our Sponsors!

LinkedIn

Instagram

Twitter

YouTube

Facebook